Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nevena Todorovic

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Infection in Developing Countries|June 12, 2024
Molnupiravir's real-world effectiveness in COVID-19 outpatients at high risk of severe disease: a single-center studyIvana I Gmizic, Aleksandra Barac, Nevena Todorovic, et al.
Biomedicines|March 28, 2026
Arterial Thrombosis in Severe Ulcerative Colitis: A Case-Based Narrative Review of Current EvidenceDjordje Kralj, Mladen Maksic, Tamara Knezevic Ivanovski, et al.
Frontiers in Molecular Biosciences|January 6, 2022
<i>GSTP1</i> and <i>GSTM3</i> Variant Alleles Affect Susceptibility and Severity of COVID-19Vesna Coric, Ivana Milosevic, Tatjana Djukic, et al.
Redox Report : Communications in Free Radical Research|April 1, 2022
<i>SOD2</i> rs4880 and <i>GPX1</i> rs1050450 polymorphisms do not confer risk of COVID-19, but influence inflammation or coagulation parameters in Serbian cohortDjurdja Jerotic, Jovan Ranin, Zoran Bukumiric, et al.
Journal of Personalized Medicine|March 25, 2022
<i>GSTO1</i>, <i>GSTO2</i> and <i>ACE2</i> Polymorphisms Modify Susceptibility to Developing COVID-19Tatjana Djukic, Goran Stevanovic, Vesna Coric, et al.
Antioxidants (Basel, Switzerland)|May 28, 2022
Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVIDMarko Ercegovac, Milika Asanin, Ana Savic-Radojevic, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Infection in Developing Countries|June 12, 2024
Molnupiravir's real-world effectiveness in COVID-19 outpatients at high risk of severe disease: a single-center studyIvana I Gmizic, Aleksandra Barac, Nevena Todorovic, et al.
Biomedicines|March 28, 2026
Arterial Thrombosis in Severe Ulcerative Colitis: A Case-Based Narrative Review of Current EvidenceDjordje Kralj, Mladen Maksic, Tamara Knezevic Ivanovski, et al.
Frontiers in Molecular Biosciences|January 6, 2022
<i>GSTP1</i> and <i>GSTM3</i> Variant Alleles Affect Susceptibility and Severity of COVID-19Vesna Coric, Ivana Milosevic, Tatjana Djukic, et al.
Redox Report : Communications in Free Radical Research|April 1, 2022
<i>SOD2</i> rs4880 and <i>GPX1</i> rs1050450 polymorphisms do not confer risk of COVID-19, but influence inflammation or coagulation parameters in Serbian cohortDjurdja Jerotic, Jovan Ranin, Zoran Bukumiric, et al.
Journal of Personalized Medicine|March 25, 2022
<i>GSTO1</i>, <i>GSTO2</i> and <i>ACE2</i> Polymorphisms Modify Susceptibility to Developing COVID-19Tatjana Djukic, Goran Stevanovic, Vesna Coric, et al.
Antioxidants (Basel, Switzerland)|May 28, 2022
Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVIDMarko Ercegovac, Milika Asanin, Ana Savic-Radojevic, et al.
Pageof 2